ImmuPharma PLC Shares Soar Amid Strategic Leadership Moves and Patent Filing
ImmuPharma PLC’s shares have surged 29.9% as the company makes strategic moves, including key executive appointments and a patent filing for a promising therapeutic approach targeting autoimmune diseases.
3 minutes to read